Q3 2024 Oriola Oyj Earnings Call Transcript
Key Points
- Oriola Corp (FRA:O5O) reported a 19% increase in net sales, reaching EUR424 million, with organic growth at 5%.
- The adjusted EBIT improved by 25%, reaching EUR5.5 million, driven by growth in the distribution segment and lower freight costs.
- E-commerce sales in Sweden grew by double digits, enhancing Oriola's footprint in a significant market.
- The company has signed new and renewed existing distribution agreements, indicating future growth potential.
- Oriola has successfully introduced new products and suppliers in the wholesale segment, contributing to future growth.
- Challenges in the availability of pharmaceuticals continue in both Sweden and Finland, impacting the business environment.
- The Swedish market share experienced a slight decline, partly due to not having a portfolio in the growing weight loss segment.
- The ERP project costs were higher than expected, with a significant portion being expensed rather than capitalized.
- The integration process with Krono Zute has been more complex than anticipated, delaying the realization of synergies.
- The Swedish dose dispensing business sale is facing regulatory challenges, potentially delaying the exit from this segment.
Good morning, everyone and a warm welcome to Oriola's Q3 results Webcast. My name is Tuos Dennison and I'm from Oriola's Investor Relations with me. Today. I have CEO Karina Gabrielson and our new CFO Matt Danielson.
After the presentations, we open up for your, for the Q&A and we ask you to send in your questions through the chat already during the presentation.
Also as a reminder in the Q&A, we will focus on the questions about Oriola's business and financial performance.
The webcast will be recorded and the recording will be available on our website later today without further ado, let's go to the disclaimer. So here it is. And now Catarina, please go ahead.
Thank you, Toa and warmly welcome. Also on my behalf, this is the agenda for today. It's quite traditional. We will start with the highlights and operating
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
